{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:36:13Z","timestamp":1790616973705,"version":"4.1.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.canrad.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T09:00:33Z","timestamp":1496653233000},"page":"411-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pr\u00e9vention m\u00e9dicale et traitement des complications pulmonaires secondaires \u00e0 la radioth\u00e9rapie"],"prefix":"10.1016","volume":"21","author":[{"given":"A.","family":"Vallard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rancoule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Le Floch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-B.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Espenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Le P\u00e9choux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9.","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2017.03.004_bib0005","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.ijrobp.2006.08.058","article-title":"Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research","volume":"66","author":"Tsoutsou","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0010","first-page":"180","article-title":"Pneumopathie radique\u00a0: une pathologie iatrog\u00e8ne en voie de disparition\u00a0?","volume":"2","author":"Lerouge","year":"2010","journal-title":"Rev Mal Respir Actual"},{"key":"10.1016\/j.canrad.2017.03.004_bib0015","first-page":"52","article-title":"Pathologie bronchopulmonaires radio-induites","volume":"5","author":"Jacot","year":"2002","journal-title":"Lett Pneumol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-86-1-81","article-title":"Pulmonary effects of radiation therapy","volume":"86","author":"Gross","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1034\/j.1399-3003.1999.13d05.x","article-title":"Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation","volume":"13","author":"Mart\u00edn","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.canrad.2017.03.004_bib0030","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0360-3016(02)04389-4","article-title":"Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer","volume":"55","author":"De Jaeger","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0035","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0360-3016(88)90241-6","article-title":"The association of adult respiratory distress syndrome (ARDS) with thoracic irradiation (RT)","volume":"15","author":"Byhardt","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/pgmj.2011.118398","article-title":"Acute respiratory distress syndrome and acute lung injury","volume":"87","author":"Dushianthan","year":"2011","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.canrad.2017.03.004_bib0045","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1517\/14656566.2014.938049","article-title":"The interplay between radiation and the immune system in the field of post-radical pneumonitis and fibrosis and why it is important to understand it","volume":"15","author":"Tsoutsou","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.canrad.2017.03.004_bib0050","first-page":"985","article-title":"Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis","volume":"24","author":"Choi","year":"2004","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"10.1016\/j.canrad.2017.03.004_bib0055","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0360-3016(94)00429-O","article-title":"Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems","volume":"31","author":"McDonald","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0060","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1164\/ajrccm.158.6.9711036","article-title":"Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d\u2019\u00c9tudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM\u201cO\u201dP)","volume":"158","author":"Crestani","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0065","first-page":"10","article-title":"Radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome in breast cancer patients is associated with age","author":"Murofushi","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ijrobp.2008.05.050","article-title":"Analysis of factors associated with radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy","volume":"73","author":"Katayama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0091-6749(00)90071-X","article-title":"Bronchoalveolar lavage in bronchiolitis obliterans organizing pneumonia primed by radiation therapy to the breast","volume":"105","author":"Majori","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0080","first-page":"689","article-title":"Radiation-induced bronchiolitis obliterans organizing pneumonia: a case report and literature review","volume":"10","author":"Onitilo","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1183\/09031936.95.08020318","article-title":"Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma","volume":"8","author":"Crestani","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.canrad.2017.03.004_bib0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1259\/0007-1285-50-591-224","article-title":"Reactivation of radiation pneumonitis by adriamycin","volume":"50","author":"Mclnerney","year":"1977","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0095","first-page":"641","article-title":"[A case with delayed-onset radiation pneumonitis suspected to be induced by oral etoposide]","volume":"52","author":"Kataoka","year":"1992","journal-title":"Nihon Igaku Hoshasen Gakkai Zasshi"},{"key":"10.1016\/j.canrad.2017.03.004_bib0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00066-007-1688-z","article-title":"Radiation recall pneumonitis induced by gemcitabine","volume":"183","author":"Schwarte","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7","article-title":"Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel","volume":"76","author":"Schweitzer","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2017.03.004_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000336131","article-title":"Interstitial pneumonitis after treatment with pemetrexed: a rare event?","volume":"58","author":"Hochstrasser","year":"2012","journal-title":"Chemotherapy"},{"key":"10.1016\/j.canrad.2017.03.004_bib0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1748-717X-6-24","article-title":"Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer","volume":"6","author":"Ding","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/JTO.0b013e3181a97e17","article-title":"High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin","volume":"4","author":"Arrieta","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0125","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/jnci\/93.23.1806","article-title":"Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel","volume":"93","author":"Taghian","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2017.03.004_bib0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00001622-200107000-00006","article-title":"Radiation-induced and chemotherapy-induced pulmonary injury","volume":"13","author":"Abid","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0360-3016(91)90782-Y","article-title":"Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy","volume":"21","author":"Lingos","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0140","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00280-008-0837-0","article-title":"Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer","volume":"63","author":"Nakamura","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0169-5002(02)00532-9","article-title":"Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis","volume":"40","author":"Onishi","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2017.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2006.11.003","article-title":"The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response","volume":"67","author":"Mao","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0155","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.canrad.2014.05.007","article-title":"Association d\u2019une chimioth\u00e9rapie ou d\u2019un traitement cibl\u00e9 \u00e0 une irradiation st\u00e9r\u00e9otaxique\u00a0: \u00e9tat des lieux et recommandations pr\u00e9liminaires","volume":"18","author":"Thariat","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2017.03.004_bib0160","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/JTO.0b013e31818396a4","article-title":"Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer","volume":"3","author":"Choong","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0165","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1200\/JCO.2014.56.7412","article-title":"Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer","volume":"32","author":"Iyengar","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/COC.0b013e31826e071b","article-title":"Gefitinib combined with stereotactic radiosurgery in previously treated patients with advanced non-small cell lung cancer","volume":"37","author":"Wang","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0175","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2013.11.010","article-title":"Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib","volume":"88","author":"Gan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0180","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/JTO.0b013e3182745948","article-title":"Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene addicted non-small cell lung cancer","volume":"7","author":"Weickhardt","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0185","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0190","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1200\/JCO.2010.30.3271","article-title":"European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer","volume":"28","author":"De Ruysscher","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0195","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/JTO.0b013e31824165d7","article-title":"Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?","volume":"7","author":"Guckenberger","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0200","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijrobp.2010.08.056","article-title":"A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"82","author":"Barriger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0205","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.ijrobp.2012.01.018","article-title":"Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"83","author":"Matsuo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0210","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1016\/j.prro.2014.12.002","article-title":"Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy","volume":"5","author":"Mathieu","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0215","doi-asserted-by":"crossref","first-page":"20160508","DOI":"10.1259\/bjr.20160508","article-title":"Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumors","volume":"90","author":"Okubo","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2011.09.012","article-title":"Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy","volume":"101","author":"Peulen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0225","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2009.09.070","article-title":"Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation","volume":"78","author":"Kelly","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0230","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.canrad.2016.07.054","article-title":"Chimioradioth\u00e9rapie concomitante suivie d\u2019une irradiation st\u00e9r\u00e9otaxique des cancers bronchiques non \u00e0 petites cellules\u00a0: r\u00e9sultats finaux de l\u2019essai de phase 1\u00a0Cybertaxcis","volume":"20","author":"Doyen","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2017.03.004_bib0235","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ijrobp.2009.12.041","article-title":"High-dose-rate brachytherapy for non-small-cell lung carcinoma: a retrospective study of 226\u00a0patients","volume":"79","author":"Aumont-le Guilcher","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0240","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.03.041","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung","volume":"85","author":"Baker","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0245","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ijrobp.2016.03.024","article-title":"Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88\u00a0studies","volume":"95","author":"Zhao","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0250","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejrad.2009.10.029","article-title":"Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes","volume":"79","author":"Linda","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0260","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2006.12.009","article-title":"FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer","volume":"56","author":"Hoopes","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2017.03.004_bib0265","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ijrobp.2012.09.016","article-title":"Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer","volume":"85","author":"Guckenberger","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0272-5231(03)00126-6","article-title":"Pulmonary complications of radiation therapy","volume":"25","author":"Abratt","year":"2004","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0275","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0360-3016(94)00477-3","article-title":"Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury","volume":"31","author":"Morgan","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0280","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-5002(01)00334-8","article-title":"Lung toxicity following chest irradiation in patients with lung cancer","volume":"35","author":"Abratt","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2017.03.004_bib0285","first-page":"19","article-title":"Experimental radiation pneumonitis. IV. Leakage of circulatory proteins onto the alveolar surface","volume":"95","author":"Gross","year":"1980","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0290","first-page":"382","article-title":"Cryptogenic organizing pneumonitis","volume":"52","author":"Davison","year":"1983","journal-title":"Q J Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0295","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2214\/ajr.159.6.1442375","article-title":"Radiation effects on the lung: clinical features, pathology, and imaging findings","volume":"159","author":"Davis","year":"1992","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1165\/rcmb.2002-0069OC","article-title":"Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis","volume":"29","author":"Epperly","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0305","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0248-8663(01)00532-X","article-title":"R\u00e9versibilit\u00e9 de la fibroatrophie radio-induite","volume":"23","author":"Delanian","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.canrad.2017.03.004_bib0310","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0360-3016(00)00654-4","article-title":"Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicity","volume":"48","author":"Takigawa","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0315","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1183\/09031936.06.00013505","article-title":"Cryptogenic organising pneumonia","volume":"28","author":"Cordier","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.canrad.2017.03.004_bib0320","first-page":"102","article-title":"Ultrastructural evidence of alveolar epithelial injury in idiopathic bronchiolitis obliterans-organizing pneumonia","volume":"132","author":"Myers","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0325","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/path.1038","article-title":"VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia","volume":"196","author":"Lappi-Blanco","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0330","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1164\/ajrccm.162.5.9906096","article-title":"Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias","volume":"162","author":"Suga","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0335","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/PL00007654","article-title":"Apoptotic activity is increased in the newly formed fibromyxoid connective tissue in bronchiolitis obliterans organizing pneumonia","volume":"177","author":"Lappi-Blanco","year":"1999","journal-title":"Lung"},{"key":"10.1016\/j.canrad.2017.03.004_bib0340","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1566523034578384","article-title":"Radioprotective gene therapy","volume":"3","author":"Greenberger","year":"2003","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.canrad.2017.03.004_bib0345","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canrad.2008.11.010","article-title":"Toxicit\u00e9 et efficacit\u00e9 de la radioth\u00e9rapie adjuvante chez les patientes trait\u00e9es pour un cancer du sein et porteuses d\u2019une mutation h\u00e9t\u00e9rozygote du g\u00e8ne de l\u2019ataxie-t\u00e9langiectasie","volume":"13","author":"Chargari","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2017.03.004_bib0350","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ijrobp.2012.09.024","article-title":"ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy","volume":"85","author":"Xiong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0355","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2009.07.1675","article-title":"ATM polymorphisms are associated with risk of radiation-induced pneumonitis","volume":"77","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0360","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1002\/cncr.26667","article-title":"A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy","volume":"118","author":"Mak","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2017.03.004_bib0365","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/S0021-9258(18)61441-3","article-title":"The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts","volume":"262","author":"Fine","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.canrad.2017.03.004_bib0370","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0360-3016(94)90187-2","article-title":"Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis","volume":"28","author":"Finkelstein","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0375","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2307\/3579368","article-title":"Early and persistent alterations in the expression of interleukin-1\u00a0alpha, interleukin-1\u00a0beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation","volume":"145","author":"Johnston","year":"1996","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0380","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0360-3016(95)00095-G","article-title":"A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis","volume":"33","author":"Rubin","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0385","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0360-3016(98)00154-0","article-title":"Plasma transforming growth factor beta1\u00a0as a predictor of radiation pneumonitis","volume":"41","author":"Anscher","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0390","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0360-3016(03)00184-6","article-title":"Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy","volume":"56","author":"Anscher","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0395","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijrobp.2009.04.019","article-title":"Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer","volume":"77","author":"Mazeron","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0400","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0360-3016(77)90159-6","article-title":"Pathologic changes in the lung following single and multi-fraction irradiation","volume":"2","author":"Travis","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0405","first-page":"2582","article-title":"Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo","volume":"54","author":"Fuks","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0410","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/01902149809041538","article-title":"Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and -sensitive mice after thoracic irradiation","volume":"24","author":"Johnston","year":"1998","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0415","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1671","article-title":"Radiation pneumonitis. Bronchoalveolar lavage assessment and modulation by a recombinant cytokine","volume":"148","author":"Rosiello","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.canrad.2017.03.004_bib0420","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/clin.1998.4606","article-title":"Blockade of CD40-CD40\u00a0ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis","volume":"89","author":"Adawi","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0425","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0360-3016(95)02101-9","article-title":"Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer","volume":"34","author":"Nakayama","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0430","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1165\/ajrcmb.17.3.2279","article-title":"Local production of interleukin-4\u00a0during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4","volume":"17","author":"B\u00fcttner","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0435","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/srao.2002.31360","article-title":"Radiation pneumonitis and early circulatory cytokine markers","volume":"12","author":"Chen","year":"2002","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0440","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0360-3016(00)01445-0","article-title":"Circulating IL-6\u00a0as a predictor of radiation pneumonitis","volume":"49","author":"Chen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0445","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/srao.2002.31359","article-title":"Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer","volume":"12","author":"Chao","year":"2002","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0450","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.1988.6.4.709","article-title":"Chemical modifiers of cancer treatment","volume":"6","author":"Coleman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0455","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/JCO.2010.31.5051","article-title":"Amifostine in the treatment of head and neck cancer: intravenous administration, subcutaneous administration, or none of the above","volume":"29","author":"Eisbruch","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0460","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0465","first-page":"116","article-title":"The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy","volume":"18","author":"Marcu","year":"2009","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.canrad.2017.03.004_bib0470","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2009.25.5638","article-title":"Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02\u00a0phase III randomized trial","volume":"29","author":"Bardet","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0475","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/01902140290096791","article-title":"Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity","volume":"28","author":"Vujaskovic","year":"2002","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0480","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0360-3016(01)01713-8","article-title":"Randomized phase III trial of radiation treatment\u00b1amifostine in patients with advanced-stage lung cancer","volume":"51","author":"Antonadou","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0485","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1053\/j.seminoncol.2005.03.010","article-title":"Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategies","volume":"32","author":"Gopal","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0490","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","article-title":"American Society of Clinical Oncology 2008\u00a0clinical practice guideline update: use of chemotherapy and radiation therapy protectants","volume":"27","author":"Hensley","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0495","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1200\/JCO.2005.07.167","article-title":"Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01","volume":"23","author":"Movsas","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0500","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2174\/1389450111009011386","article-title":"Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction?","volume":"11","author":"Williams","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.canrad.2017.03.004_bib0505","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2307\/3577335","article-title":"Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817","volume":"117","author":"Ward","year":"1989","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0510","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijrobp.2011.11.013","article-title":"Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy","volume":"84","author":"Kharofa","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0515","first-page":"262","article-title":"Pentoxifylline in vivo down-regulates the release of IL-1\u00a0beta, IL-6, IL-8\u00a0and tumour necrosis factor-alpha by human peripheral blood mononuclear cells","volume":"83","author":"Neuner","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.canrad.2017.03.004_bib0520","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(03)01444-5","article-title":"Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial","volume":"58","author":"Ozturk","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.03.004_bib0525","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12032-007-0006-z","article-title":"Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer","volume":"24","author":"Misirlioglu","year":"2007","journal-title":"Med Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0530","doi-asserted-by":"crossref","first-page":"e112731","DOI":"10.1371\/journal.pone.0112731","article-title":"Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity","volume":"9","author":"Seidensticker","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.canrad.2017.03.004_bib0535","first-page":"211","article-title":"Corticosteroids and azathioprine do not prevent radiation-induced lung injury","volume":"5","author":"Kwok","year":"1998","journal-title":"Can Respir J"},{"key":"10.1016\/j.canrad.2017.03.004_bib0540","series-title":"Strategies to enhance the therapeutic ratio of radiation as a cancer treatment","author":"Anscher","year":"2016"},{"key":"10.1016\/j.canrad.2017.03.004_bib0545","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4255\/mcpharmacol.09.06","article-title":"Role of radiation-induced TGF-beta signaling in cancer therapy","volume":"1","author":"Dancea","year":"2009","journal-title":"Mol Cell Pharmacol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0550","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.mehy.2013.01.001","article-title":"The effect of Halofuginone in the amelioration of radiation induced-lung fibrosis","volume":"80","author":"Yavas","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.canrad.2017.03.004_bib0555","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/molecules20010573","article-title":"Halofuginone \u2013\u00a0the multifaceted molecule","volume":"20","author":"Pines","year":"2015","journal-title":"Molelcules"},{"key":"10.1016\/j.canrad.2017.03.004_bib0560","series-title":"Increasing the therapeutic ratio of radiotherapy","author":"Tofilon","year":"2017"},{"key":"10.1016\/j.canrad.2017.03.004_bib0565","doi-asserted-by":"crossref","first-page":"e1123366","DOI":"10.1080\/2162402X.2015.1123366","article-title":"Combined inhibition of TGF\u03b2 and PDGF signaling attenuates radiation-induced pulmonary fibrosis","volume":"5","author":"Dadrich","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canrad.2017.03.004_bib0570","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3109\/09553001003674863","article-title":"Imatinib therapy reduces radiation-induced pulmonary mast cell influx and delays lung disease in the mouse","volume":"86","author":"Thomas","year":"2010","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0575","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.gt.3300580","article-title":"Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy","volume":"5","author":"Epperly","year":"1998","journal-title":"Gene Ther"},{"key":"10.1016\/j.canrad.2017.03.004_bib0580","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1667\/0033-7587(2000)154[0365:DPRROM]2.0.CO;2","article-title":"Decreased pulmonary radiation resistance of manganese superoxide dismutase (MnSOD)-deficient mice is corrected by human manganese superoxide dismutase-plasmid\/liposome (SOD2-PL) intratracheal gene therapy","volume":"154","author":"Epperly","year":"2000","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0585","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/bbmt.1999.v5.pm10465100","article-title":"Manganese [correction of magnesium] superoxide dismutase (MnSOD) plasmid\/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis\/fibrosis","volume":"5","author":"Epperly","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.canrad.2017.03.004_bib0590","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1089\/hum.2007.141","article-title":"Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene","volume":"19","author":"Zhang","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.canrad.2017.03.004_bib0595","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.freeradbiomed.2007.10.058","article-title":"Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection","volume":"44","author":"Gauter-Fleckenstein","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0600","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1667\/RR1948.1","article-title":"Novel synthetic SOD\/catalase mimetics can mitigate capillary endothelial cell apoptosis caused by ionizing radiation","volume":"173","author":"Vorotnikova","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0605","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0167-8140(02)00325-0","article-title":"Partial volume rat lung irradiation; assessment of early DNA damage in different lung regions and effect of radical scavengers","volume":"66","author":"Khan","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0610","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3109\/09553002.2011.583315","article-title":"Mitigation of radiation-induced lung injury by genistein and EUK-207","volume":"87","author":"Mahmood","year":"2011","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0615","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1667\/RR1896.1","article-title":"Genistein can mitigate the effect of radiation on rat lung tissue","volume":"173","author":"Calveley","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0620","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","article-title":"Rho GTPases, statins, and nitric oxide","volume":"97","author":"Rikitake","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0625","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1074\/jbc.M513000200","article-title":"Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism","volume":"281","author":"Mason","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.canrad.2017.03.004_bib0630","doi-asserted-by":"crossref","first-page":"34P","DOI":"10.1016\/j.amjcard.2006.09.018","article-title":"Molecular basis of differences among statins and a comparison with antioxidant vitamins","volume":"98","author":"Mason","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0635","doi-asserted-by":"crossref","first-page":"I11","DOI":"10.1002\/clc.4960261305","article-title":"Effects of statins in reducing thrombotic risk and modulating plaque vulnerability","volume":"26","author":"Libby","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0640","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/1389450111009011395","article-title":"Modulation of the Rho\/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity","volume":"11","author":"Monceau","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.canrad.2017.03.004_bib0645","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.radonc.2009.06.020","article-title":"Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo","volume":"92","author":"Ostrau","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0650","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1667\/RR3168","article-title":"Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model","volume":"161","author":"Williams","year":"2004","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0655","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1440-1681.2006.04440.x","article-title":"Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury","volume":"33","author":"Yao","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0660","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/147323000703500412","article-title":"Effects of simvastatin on lung injury induced by ischaemia-reperfusion of the hind limbs in rats","volume":"35","author":"Sun","year":"2007","journal-title":"J Int Med Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0665","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/jco.2011.29.7_suppl.26","article-title":"Radiosensitization of MYC-overexpressing prostate cancer cells by statins","volume":"29","author":"Salih","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0670","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PPO.0b013e31829453fb","article-title":"Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung)","volume":"19","author":"Yazbeck","year":"2013","journal-title":"Cancer J"},{"key":"10.1016\/j.canrad.2017.03.004_bib0675","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.7314\/APJCP.2015.16.7.2613","article-title":"Radiation induced lung injury: prediction, assessment and management","volume":"16","author":"Giridhar","year":"2015","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.canrad.2017.03.004_bib0680","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4065\/74.1.27","article-title":"Radiation-induced pneumonitis in the \u201cnonirradiated\u201d lung","volume":"74","author":"Arbetter","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.canrad.2017.03.004_bib0685","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2307\/3577184","article-title":"Protective effect of corticosteroids on radiation pneumonitis in mice","volume":"113","author":"Gross","year":"1988","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0690","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2169\/internalmedicine.41.730","article-title":"Corticosteroid refractory radiation pneumonitis that remarkably responded to cyclosporin A","volume":"41","author":"Muraoka","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0695","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.109.5.1397","article-title":"Azathioprine as a steroid-sparing agent in radiation pneumonitis","volume":"109","author":"McCarty","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.canrad.2017.03.004_bib0700","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14712\/18059694.2019.81","article-title":"The alveolar septal thickness and type II pneumocytes number in irradiated lungs, time expression and the effect of pentoxifylline","volume":"44","author":"Osterreicher","year":"2001","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.canrad.2017.03.004_bib0705","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1667\/RR13350.1","article-title":"Enalapril mitigates radiation-induced pneumonitis and pulmonary fibrosis if started 35\u00a0days after whole-thorax irradiation","volume":"180","author":"Gao","year":"2013","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2017.03.004_bib0710","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/095530000138538","article-title":"Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1\u00a0receptor blocker","volume":"76","author":"Molteni","year":"2000","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2017.03.004_bib0715","doi-asserted-by":"crossref","first-page":"e0121257","DOI":"10.1371\/journal.pone.0121257","article-title":"Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis","volume":"10","author":"Ni","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.canrad.2017.03.004_bib0720","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S2213-2600(16)00022-9","article-title":"NICE guidance on nintedanib for treating idiopathic pulmonary fibrosis","volume":"4","author":"Laurenson","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.canrad.2017.03.004_bib0725","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/thoraxjnl-2015-207011","article-title":"Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3\u00a0trials in patients with idiopathic pulmonary fibrosis","volume":"71","author":"Nathan","year":"2016","journal-title":"Thorax"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817301270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817301270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:26:14Z","timestamp":1761135974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321817301270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":145,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1278321817301270"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2017.03.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pr\u00e9vention m\u00e9dicale et traitement des complications pulmonaires secondaires \u00e0 la radioth\u00e9rapie","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2017.05.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}